National Pension Service Boosts Stake in Monsanto Company (NYSE:MON)
National Pension Service boosted its stake in Monsanto Company (NYSE:MON) by 13.0% during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 364,845 shares of the basic materials company’s stock after buying an additional 41,999 shares during the period. National Pension Service’s holdings in Monsanto were worth $43,052,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. DnB Asset Management AS boosted its position in shares of Monsanto by 4.6% in the first quarter. DnB Asset Management AS now owns 99,357 shares of the basic materials company’s stock valued at $11,247,000 after buying an additional 4,400 shares during the period. Capital Investment Advisors LLC boosted its position in shares of Monsanto by 0.7% in the first quarter. Capital Investment Advisors LLC now owns 4,485 shares of the basic materials company’s stock valued at $508,000 after buying an additional 29 shares during the period. Moon Capital Management LLC boosted its position in shares of Monsanto by 1.7% in the first quarter. Moon Capital Management LLC now owns 18,685 shares of the basic materials company’s stock valued at $2,115,000 after buying an additional 305 shares during the period. Washington Trust Bank boosted its position in shares of Monsanto by 579.5% in the first quarter. Washington Trust Bank now owns 3,805 shares of the basic materials company’s stock valued at $431,000 after buying an additional 3,245 shares during the period. Finally, Wealth Enhancement Advisory Services LLC purchased a new position in shares of Monsanto during the first quarter valued at approximately $824,000. 75.31% of the stock is owned by hedge funds and other institutional investors.
Monsanto Company (NYSE MON) traded down 0.25% on Thursday, hitting $117.05. The company had a trading volume of 509,585 shares. The firm has a market capitalization of $51.42 billion, a PE ratio of 25.28 and a beta of 1.07. The firm has a 50-day moving average price of $117.49 and a 200-day moving average price of $115.01. Monsanto Company has a 12-month low of $97.35 and a 12-month high of $118.97.
Monsanto (NYSE:MON) last announced its quarterly earnings data on Wednesday, June 28th. The basic materials company reported $1.93 earnings per share for the quarter, topping the consensus estimate of $1.74 by $0.19. Monsanto had a return on equity of 45.26% and a net margin of 14.11%. The business had revenue of $4.23 billion during the quarter, compared to the consensus estimate of $4.18 billion. During the same period in the prior year, the company earned $2.17 EPS. Monsanto’s revenue for the quarter was up 1.0% on a year-over-year basis. On average, equities research analysts anticipate that Monsanto Company will post $4.89 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which was paid on Friday, July 28th. Shareholders of record on Friday, July 7th were given a $0.54 dividend. The ex-dividend date of this dividend was Wednesday, July 5th. This represents a $2.16 annualized dividend and a yield of 1.84%. Monsanto’s dividend payout ratio is presently 46.75%.
Several research analysts recently commented on the company. BidaskClub raised Monsanto from a “sell” rating to a “hold” rating in a research report on Thursday, June 29th. Barclays PLC lifted their price objective on Monsanto from $115.00 to $120.00 and gave the company an “equal weight” rating in a report on Thursday, June 29th. Royal Bank Of Canada reissued a “sector perform” rating and set a $128.00 price objective (up from $120.00) on shares of Monsanto in a report on Thursday, June 29th. Zacks Investment Research cut Monsanto from a “buy” rating to a “hold” rating in a report on Tuesday, July 4th. Finally, Citigroup Inc. reissued a “neutral” rating and set a $126.00 price objective (up from $125.00) on shares of Monsanto in a report on Monday, July 10th. Two equities research analysts have rated the stock with a sell rating, eleven have given a hold rating and eight have given a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus target price of $123.15.
In other Monsanto news, EVP Robert T. Fraley sold 52,410 shares of the stock in a transaction dated Monday, July 10th. The stock was sold at an average price of $117.95, for a total value of $6,181,759.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Steven Mizell sold 11,300 shares of the stock in a transaction dated Monday, July 3rd. The shares were sold at an average price of $118.57, for a total value of $1,339,841.00. Following the completion of the transaction, the executive vice president now owns 55,011 shares of the company’s stock, valued at $6,522,654.27. The disclosure for this sale can be found here. Insiders sold 74,470 shares of company stock valued at $8,791,281 over the last quarter. Corporate insiders own 0.79% of the company’s stock.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Company (NYSE:MON).
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with Analyst Ratings Network's FREE daily email newsletter.